A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia

导出原文传递

翻译打印收藏纠错

作者： How, Jonathan ^[1] ; Minden, Mark D. ^[2] ; Brian, Leber ^[3] ; Chen, Eric X. ; Brandwein, Joseph ; Schuh, Andre C. ; Schimmer, Aaron D. ; Gupta, Vikas ; Webster, Sheila ; Degelder, Tammy ; Haines, Patricia ; Stayner, Lee-Anne ; McGill, Shauna ; Wang, Lisa ; Piekarz, Richard ; Wong, Tracy ; Siu, Lillian L. ; Espinoza-Delgado, Igor ; Holleran, Julianne L. ; Egorin, Merrill J. ; Yee, Karen W. L.

作者单位： Princess Margaret Phase I Consortium, Toronto, ON, Canada ^[1] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA ^[2] NCI, Invest Drug Branch, Canc Therapy Evaluat Program, Div Canc Treatment & Diag, Bethesda, MD ^[3]

关键词 Decitabine vorinostat hypomethylating agent histone deacetylase inhibitor acute myeloid leukemia

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交